Exalenz Bioscience Ltd (EXEN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Exalenz Bioscience Ltd (EXEN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7093
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exalenz Bioscience Ltd (Exalenz) carries out the development and commercialization of advanced medical systems for a range of gastrointestinal (GI) tract and liver disorders. The company harnesses its BreathID technology platform for assessment and monitoring of functional diseases. Its flagship product, BreathID Hp is a US FDA approved and CE marked urea breath test for diagnosing, monitoring and managing gastric Helicobacter pylori (H. pylori) infection in adults. It also offers BreathID 13C-methacetin breath test, a non-invasive point of care tool measures the microsomal function of the liver. It works in collaboration with various clinical and industrial partners in Europe, Asia, the US and Israel. Exalenz is headquartered in Modiin, Israel.

Exalenz Bioscience Ltd (EXEN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Exalenz Bioscience Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Exalenz Bioscience Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Exalenz Bioscience Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Exalenz Bioscience Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Exalenz Bioscience Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Exalenz Bioscience Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Exalenz Bioscience Partners with Conatus Pharma 10
Exalenz Bioscience Enters into Agreement with ALFSG 11
Equity Offering 12
Exalenz Bioscience Files Registration Statement to Raise Funds through Public Offering of Shares 12
Exalenz Bioscience Completes Rights Offering Of Shares For US$7.8 Million 13
Exalenz Bioscience Ltd – Key Competitors 14
Exalenz Bioscience Ltd – Key Employees 15
Exalenz Bioscience Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Aug 31, 2018: Exalenz Bioscience announces second quarter 2018 financial results 17
Mar 12, 2018: Exalenz Announces Fourth Quarter and Full Year 2017 Financial Results 19
Corporate Communications 20
Apr 30, 2018: Exalenz Bioscience Appoints Roy Golan as President and Chief Financial Officer 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Exalenz Bioscience Ltd, Medical Equipment, Key Facts, 2017 2
Exalenz Bioscience Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Exalenz Bioscience Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Exalenz Bioscience Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Exalenz Bioscience Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Exalenz Bioscience Ltd, Deals By Market, 2012 to YTD 2018 8
Exalenz Bioscience Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Exalenz Bioscience Partners with Conatus Pharma 10
Exalenz Bioscience Enters into Agreement with ALFSG 11
Exalenz Bioscience Files Registration Statement to Raise Funds through Public Offering of Shares 12
Exalenz Bioscience Completes Rights Offering Of Shares For US$7.8 Million 13
Exalenz Bioscience Ltd, Key Competitors 14
Exalenz Bioscience Ltd, Key Employees 15
Exalenz Bioscience Ltd, Subsidiaries 16

List of Figures
Exalenz Bioscience Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Exalenz Bioscience Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Exalenz Bioscience Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Exalenz Bioscience Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Exalenz Bioscience Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Exalenz Bioscience Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Exalenz Bioscience Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Exalenz Bioscience Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Exalenz Bioscience Ltd (EXEN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pulsion Medical Systems SE (PUS):医療機器:M&Aディール及び事業提携情報
    Summary Pulsion Medical Systems SE (Pulsion Medical Systems), formerly Pulsion Medical Systems AG, a subsidiary of Getinge AB, is a medical device company that manufactures and develops critical care systems and monitors. The company’s products include ProAQT sensor, PiCCO catheter, CeVOX module, Pi …
  • Cielo Wind Power, LP:電力:M&Aディール及び事業提携情報
    Summary Cielo Wind Power, LP (Cielo Wind) is a wind power project development company. It designs, develops, owns and operates utility-grade wind power projects. The company provides a wide range of services including engineering, construction, operations and maintenance, land procurement, meteorolo …
  • Air Canada:戦略・SWOT・企業財務分析
    Air Canada - Strategy, SWOT and Corporate Finance Report Summary Air Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • American Overseas Group Limited
    American Overseas Group Limited - Strategy, SWOT and Corporate Finance Report Summary American Overseas Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Integrated Sensing Systems Inc:企業の製品パイプライン分析2018
    Summary Integrated Sensing Systems Inc (ISSYS) is a technology company that provides scientific sensing applications. The company provides business units such as medical, fluidic, foundry services, nanogetters, and others. designs and manufactures measurement instruments and sensors. Its medical uni …
  • Kuwait Food Company (Americana) KSCP:企業の戦略的SWOT分析
    Kuwait Food Company (Americana) KSCP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Software AG:企業の戦略・SWOT・財務分析
    Software AG - Strategy, SWOT and Corporate Finance Report Summary Software AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Just Energy Group Inc. (JE)-エネルギー分野:企業M&A・提携分析
    Summary Just Energy Group Inc. (Just Energy) is a provider of energy management solutions. The company offers natural gas, electricity, solar energy, green energy and energy efficiency tools and products to customers. It serves consumer and commercial markets through fixed price contracts, variable- …
  • GDI Integrated Facility Services Inc (GDI):企業の財務・戦略的SWOT分析
    Summary GDI Integrated Facility Services Inc (GDI), formery Medwell Capital Corp is a commercial facility service provider. The company’s services include cleaning, food plant sanitation, technical trade services and energy management, healthcare sanitation, hotel support, event support and disaster …
  • Luxoft Holding Inc:企業の戦略・SWOT・財務分析
    Luxoft Holding Inc - Strategy, SWOT and Corporate Finance Report Summary Luxoft Holding Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nizhnekamskneftekhim (NKNC):企業の財務・戦略的SWOT分析
    Nizhnekamskneftekhim (NKNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Idexx Laboratories Inc (IDXX):企業の財務・戦略的SWOT分析
    Idexx Laboratories Inc (IDXX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Maxeda B.V.:戦略・SWOT・企業財務分析
    Maxeda B.V. - Strategy, SWOT and Corporate Finance Report Summary Maxeda B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Strongbridge Biopharma plc (SBBP):企業の財務・戦略的SWOT分析
    Summary Strongbridge Biopharma Plc (Strongbridge Biopharma), formerly Cortendo Plc is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases. The company’s marketed product KEVEYIS (dichlorphenamide) is indicated for the treatment of hypokalemic, hy …
  • WNS (Holdings) Limited:企業の戦略・SWOT・財務情報
    WNS (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary WNS (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cancer Research Technology Ltd-医療機器分野:企業M&A・提携分析
    Summary Cancer Research Technology Ltd (CRT), formerly Cancer Research Campaign Technology Ltd, a subsidiary of Cancer Research UK, is a research organization that develops and commercializes discoveries for treatment in the areas of cancer. The organization offers services such as project developme …
  • International Isotopes Inc (INIS)-医療機器分野:企業M&A・提携分析
    Summary International Isotopes Inc (INIS) is a provider of medical teletherapy products. The company offers radioisotope products for cancer therapy, nuclear medicine and industrial processes. It offers cobalt and radiochemical products and nuclear medicine calibration standards. INIS's cobalt and r …
  • AngloGold Ashanti Limited:戦略・SWOT・企業財務分析
    AngloGold Ashanti Limited - Strategy, SWOT and Corporate Finance Report Summary AngloGold Ashanti Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Caspian Energy Inc (CKZ.H):石油・ガス:M&Aディール及び事業提携情報
    Summary Caspian Energy Inc (CEI) is an independent upstream oil and gas company. It carries out the exploration, development, and production of oil and gas. and the company, along with its subsidiaries hold interests in Aral Petroleum Capital LLP, which holds an exclusive license to explore and deve …
  • Inovio Pharmaceuticals Inc (INO):医療機器:M&Aディール及び事業提携情報
    Summary Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing a portfolio of DNA immunotherapies and vaccines for the treatment and prevention of various cancers and infectious diseases. The company develops products based on its core SynCon DNA plasmid technology …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆